Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 72Precursor Cell Lymphoblastic Leukemia-Lymphoma 66Lymphoma, Large B-Cell, Diffuse 53Lymphoma, Non-Hodgkin 33Leukemia 33Burkitt Lymphoma 33Lymphoma, Mantle-Cell 20Lymphoma, Follicular 19Recurrence 13Lymphoma, B-Cell 13Hodgkin Disease 13Neoplasms 11Lymphoma, Large-Cell, Anaplastic 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Sarcoma 9Neuroblastoma 8Multiple Myeloma 8Medulloblastoma 8Lymphoma, T-Cell, Peripheral 8Lymphoma, T-Cell 7Central Nervous System Neoplasms 7Rhabdomyosarcoma 6Leukemia, Biphenotypic, Acute 6Lymphoma, B-Cell, Marginal Zone 5Wilms Tumor 4Waldenstrom Macroglobulinemia 4Sarcoma, Ewing 4Rhabdoid Tumor 4Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Large-Cell, Immunoblastic 4

Interventions

Temozolomide 4Carboplatin 3Bevacizumab 3Radiotherapy 2Immunoglobulin G 2Disulfides 2etoposide phosphate 1Vorinostat 1Vincristine 1Surveys and Questionnaires 1Standard of Care 1Radiosurgery 1Radiation 1Microarray Analysis 1Lomustine 1Lapatinib 1Irinotecan 1Immunohistochemistry 1Ifosfamide 1Fluorodeoxyglucose F18 1Erlotinib Hydrochloride 1Donepezil 1Dasatinib 1Cryosurgery 1Blotting, Western 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Spinal Cord Neoplasms × Vincristine × Clear all
NCT00077207 2018-05-16

Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma

Children's Oncology Group

Phase NA Completed
66 enrolled 13 charts
CNS

Brain Neoplasms, Oligodendroglioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡